BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

21 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia.EBI
Broad Institute
Fused tricyclic compounds as Raf kinase inhibitorsBDB
Beigene
4-imidazopyridazin-1-yl-benzamides as BTK inhibitorsBDB
Merck Sharp & Dohme
RIPK2 inhibitors and method of treating cancer with sameBDB
University Health Network
Triaza-spirodecanones as DDR1 inhibitorsBDB
Hoffmann-La Roche
TRPV1 vanilloid receptor antagonists with a bicyclic portionBDB
TBA
Ghrelin 0-acyl transferase inhibitorsBDB
Eli Lilly
Benzimidazole derivatives and use thereofBDB
Purdue Pharma
COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOFBDB
Ono Pharmaceutical
Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.BDB
University of Maryland
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.BDB
Yamanouchi Pharmaceutical
2-[2-methylazetidin-1-yl]-4-phenyl-6-(trifluoromethyl)-pyrimidine compoundsBDB
Eli Lilly
Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.BDB
Research Triangle Institute
Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.BDB
Aristotle University
(3R,5S,E)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic Acid (BMS-644950): A Rationally Designed Orally Efficacious 3-Hydroxy-3-methylglutaryl Coenzyme-A Reductase Inhibitor with Reduced Myotoxicity Potential.BDB
Bristol-Myers Squibb
Synthesis and pharmacological evaluation of 1,2-dihydrospiro[isoquinoline-4(3H),4'-piperidin]-3-ones as nociceptin receptor agonists.BDB
Istituto Superiore Di Sanita
Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors.BDB
Lund University
Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-beta Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-beta Receptor Type I Inhibitor as Antitumor Agent.BDB
Eli Lilly
2-Amino-N-pyrimidin-4-ylacetamides as A2A Receptor Antagonists: 1. Structure-Activity Relationships and Optimization of Heterocyclic Substituents.BDB
Neuroscience
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.BDB
Eli Lilly
Use of binding enthalpy to drive an allosteric transition.BDB
University of Maryland